Epidermal growth factor contamination and concentrations of intact human chorionic gonadotropin in commercial preparations
- 31 July 2004
- journal article
- research article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 82 (1), 232-233
- https://doi.org/10.1016/j.fertnstert.2003.11.051
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Prion transmission in blood and urine: what are the implications for recombinant and urinary-derived gonadotrophins?Human Reproduction, 2002
- Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (OvidrelR) to urinary hCG (ProfasiR) for induction of final follicular maturation in in vitro fertilization–embryo transferFertility and Sterility, 2001
- Eosinophil derived neurotoxin (EDN) levels in commercial human urinary preparations of glycoprotein hormonesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1999
- Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormoneNature, 1995
- The detection and isolation of protease activity associated with purified preparations of human chorionic gonadotropin.Endocrinology, 1993
- Epidermal growth factor in urine of pregnant women and in amniotic fluid throughout pregnancyGynecological Endocrinology, 1990
- Characterization of epidermal growth factor-related proteins from human urinary chorionic gonadotrophinJournal of Endocrinology, 1989
- Heterogeneity of Proteins in Commercial Preparations of Human Chorionic Gonadotropin (hCG) Demonstrated by Western BlottingAmerican Journal of Reproductive Immunology, 1988
- Alteration of the growth of cytomegalovirus and herpes simplex virus type 1 by epidermal growth factor, a contaminant of crude human chorionic gonadotropin preparations.JCI Insight, 1978